Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof
    16.
    发明授权
    Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof 失效
    抗菌1-(4-单和二卤甲基磺酰基苯基)-2-酰基氨基-3-氟丙酮及其制备方法

    公开(公告)号:US07361689B2

    公开(公告)日:2008-04-22

    申请号:US11018156

    申请日:2004-12-21

    Abstract: Novel florfenicol compounds having the chemical structure: or a pharmaceutically-acceptable salt thereof or a solvate thereof, or prodrug thereof, wherein R1 is CHCl2, CHClF, CHF2, CHBrCl, CH3, CH2N3, CH2CN, CH(R2)NH2 or CH X1X2; where R2 is H, CH3 or CH2OH, and X1 and X2 are independently selected halogens; and R3 is CH2Cl, CH2F, CHF2, CHCl2 or CH2OH are disclosed. The compounds are useful for the treatment and/or prevention of bacterial infections in a broad range of patients such as, without limitation, birds, fish, shellfish and mammals.

    Abstract translation: 具有化学结构的新型氟苯尼考化合物:或其药学上可接受的盐或其溶剂化物或其前药,其中R 1是CHCl 2,CHClF,CHF CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 2 CH 3 CH (R 2)NH 2或CH X 1 X 2 2; 其中R 2是H,CH 3或CH 2 OH,X 1和X 2 是独立选择的卤素; 和R 3是CH 2 CH 2,CH 2 F,CHF 2,CHCl 2, SUB或CH 2 OH。 该化合物可用于治疗和/或预防广泛范围的患者中的细菌感染,例如但不限于鸟类,鱼类,贝类和哺乳动物。

    4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents
    19.
    发明授权
    4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives as antitumor agents 失效
    4-氧杂-1-氮杂双环[3,2,0]庚-7-酮衍生物作为抗肿瘤剂

    公开(公告)号:US5561126A

    公开(公告)日:1996-10-01

    申请号:US362490

    申请日:1995-03-16

    CPC classification number: A61K31/42

    Abstract: The present invention relates to the use of 4-oxa-1-azabicyclo [3,2,0] heptan-7-one derivatives of formula (I) or a pharmaceutically acceptable salt thereof, as antitumor agents. ##STR1## Wherein R is --OCOR.sub.1 group wherein R.sub.1 is hydrogen atom, a C.sub.1-9 alkyl group which may be substituted by either one or two substituents selected together from halogen atom, hydroxy, carboxy group or (3RS,5SR)-(4-oxo-1-azabicyclo[3,2,0]heptan-7-one-3-yl) methyloxycarbonyl, a C.sub.2-17 alkenyl group, which may be substituted by carboxy group or (3RS,5SR)-(4-oxa-1-azabicyclo [3,2,0]heptan-7-one-3-yl)methyloxycarbonyl, A C.sub.2-4 alkynyl group, a C.sub.3-6 cycloalkyl group which may be substituted by carboxy group or phenyl group which may have 1, 2 or 3 substituents selected from the group consisting of cyano group, halogen atom, C.sub.1-6 alkoxy group which may be substituted by carboxy group, C.sub.1-6 alkyl group, amino group or hydroxy group.--OR.sub.2 wherein R.sub.2 is a hydrogen atom or benzyl group which may be substituted by 1 or 2 C.sub.1-6 alkoxy group.--S(O).sub.n R.sub.3 wherein R.sub.3 is phenyl group or a benzyl group which may be substituted by C.sub.1-6 alkyl group, n is 0, 1, or 2;or --CH.sub.2 OH.

    Abstract translation: PCT No.PCT / GB93 / 01435 Sec。 371日期1995年3月16日 102(e)1995年3月16日PCT PCT 1993年7月8日PCT公布。 公开号WO94 / 01109 1994年1月20日的日本本发明涉及式(I)的4-氧杂-1-氮杂双环[3,2,0]庚-7-酮衍生物或其药学上可接受的盐作为抗肿瘤剂。 (I)其中R是-OCOR1基团,其中R1是氢原子,可以被一个或两个选自卤原子,羟基,羧基或(3RS,5SR)的取代基取代的C1-9烷基, - (4-氧代-1-氮杂双环[3,2,0]庚-7-酮-3-基)甲氧基羰基,可被羧基取代的C 2-7烯基或(3RS,5SR) - ( 4-氧杂-1-氮杂双环[3,2,0]庚-7-酮-3-基)甲氧基羰基,C 2-4炔基,可被羧基或苯基取代的C 3-6环烷基, 可以具有1,2或3个选自氰基,卤素原子,可被羧基,C 1-6烷基,氨基或羟基取代的C 1-6烷氧基的取代基。 -OR 2,其中R 2是可被1或2个C 1-6烷氧基取代的氢原子或苄基。 -S(O)n R 3,其中R 3是苯基或可被C 1-6烷基取代的苄基,n是0,1或2; 或-CH 2 OH。

Patent Agency Ranking